Vanguard Capital Management’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMX
SVCM
OM
Vanguard Capital Management's IMMX Position: Q3 2026 in Review
Vanguard Capital Management increased its Immix Biopharma (IMMX) stake by 20% in Q3 2026, buying an estimated $5.6M and bringing the position to 3,002,000 shares worth $31.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2157.
Vanguard Capital Management first reported a position in IMMX in Q1 2026 and has held it in 3 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.
- Vanguard Capital Management held 3,002,000 shares of Immix Biopharma worth $31.2M as of Q3 2026.
- Vanguard Capital Management bought 494,878 Immix Biopharma shares in Q3 2026, an estimated $5.6M.
- Immix Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2157 holding.
- Vanguard Capital Management first reported a position in Immix Biopharma in Q1 2026 and has held it in 3 quarters since.
- 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.